Dialybrid’s team Dialybrid’s team Silkothane® Arteriovenous Graft is a novel hybrid arteriovenous graft engineered to integrate into patients’ vessels and provide a safe, easy-to-cannulate, durable, vascular access for hemodialysis in patients with end-stage kidney disease€15 million Series A led by new investor XGEN Venture, with…

Read More

Editor' Pick

Canada News

Lifestyle

Tech & Innovation

Latest News